Skip to content
NVRNVRNVRL15L15L15

Drawing based on the description in the official product monograph. No photo yet.

“15 mg tablets: Ovaloid curved white to almost white tablet with "NVR" debossed on one side and "L15" debossed on the other side”

NVR L15 pill

Pill with imprint NVR L15 is white, oval and has been identified as Ruxolitinib Phosphate 15 mg. It is used for polycythemia vera and primary myelofibrosis. It is supplied by Novartis Pharmaceuticals Canada Inc.

Sold in Canada

Ruxolitinib Phosphate 15 mg

Brand
Jakavi
Imprint
NVR L15
Strength
15 mg
Used for
Polycythemia vera and primary myelofibrosis
Color
White
Shape
Oval
Form
Tablet
Manufacturer
Novartis Pharmaceuticals Canada Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02388014

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ruxolitinib pills and guides

What is Ruxolitinib used for?

Ruxolitinib is used for polycythemia vera and primary myelofibrosis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Myelofibrosis

JAKAFI/JAKAFI XR is indicated for treatment of intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF in adults.

Polycythemia Vera

JAKAFI/JAKAFI XR is indicated for treatment of polycythemia vera (PV) in adults who have had an inadequate response to or are intolerant of hydroxyurea.

Acute Graft-Versus-Host Disease

JAKAFI/JAKAFI XR is indicated for treatment of steroid-refractory acute graft-versus-host disease (aGVHD) in adult and pediatric patients 12 years and older.

Chronic Graft-Versus-Host Disease

JAKAFI/JAKAFI XR is indicated for treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.

From the FDA-approved label on DailyMed (published Aug 03, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows NVR L15. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, oval.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Jakavi by Novartis Pharmaceuticals Canada Inc.

In Canada: prescription only.

Ingredients

Active: Ruxolitinib (Ruxolitinib Phosphate)

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Ruxolitinib pills